Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation

Oncogene volume 18, pages 19–25 (1999)Cite this article

Abstract

Although cyclin D1 plays a major role during cell cycle progression and is involved in human tumourigenesis, its domain structure is still poorly understood. In the present study, we have generated a series of cyclin D1 N- and C-terminal deletion constructs. These mutants were used to define the domains required for transformation of rat embryonal fibroblasts (REF) in cooperation with activated Ha-ras and and to establish correlations with defined biochemical properties of cyclin D1. Protein binding and REF assays showed that the region of the cyclin box required for the interaction with CDK4 as well as C-terminal sequences determining protein stability were crucial for transformation. Surprisingly, however, the N-terminal deletion of 20 amino acids which impaired pRb kinase activity did not affect the transforming ability of cyclin D1. Likewise, no effect on transformation was observed with mutants defective in p21CIP interaction. These observations argue against a crucial role of pRb inactivation or p21CIP squelching in cyclin D1-mediated transformation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Ausubel MF, Brent R, Kinston RE, Moore DD, Seidman JG, Smith JA and Struhl K. . 1991 Wiley-Interscience 13.6.3.

  • Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW and Adams JM. . 1994 EMBO J. 13: 2124–2130.

  • Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA and Sutherland RL. . 1993 Oncogene 8: 2127–2133.

  • Choi YH, Lee SJ, Nguyen P, Jang JS, Lee J, Wu ML, Takano E, Maki M, Henkart PA and Trepel JB. . 1997 J. Biol. Chem. 272: 28479–28484.

  • Diehl JA and Sherr CJ. . 1997 Mol. Cell. Biol. 17: 7362–7374.

  • Dingwall C and Laskey RA. . 1991 Trends Biochem. Sci. 16: 478–481.

  • Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A and Weinberg RA. . 1993 Cell 73: 499–511.

  • Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J and Livingston DM. . 1993 Cell 73: 487–497.

  • Goubin F and Ducommun B. . 1995 Oncogene 10: 2281–2287.

  • Graham FL and van der Eb AJ. . 1973 Virology 52: 456–467.

  • Han EK, Lim JT, Arber N, Rubin MA, Xing WQ and Weinstein IB. . 1998 Prostate 35: 95–101.

  • Hinds PW, Dowdy SF, Eaton EN, Arnold A and Weinberg RA. . 1994 Proc. Natl. Acad. Sci. USA 91: 709–713.

  • Jooss KU, Funk M and Müller R. . 1994 EMBO J. 13: 1467–1475.

  • Kato J, Matsushime H, Hiebert SW, Ewen ME and Sherr CJ. . 1993 Genes Dev. 7: 331–342.

  • Lammie GA and Peters G. . 1991 Cancer Cells 3: 413–420.

  • Land H, Parada LF and Weinberg RA. . 1983 Nature 304: 596–602.

  • Lech K, Anderson K and Brent R. . 1988 Cell 52: 179–184.

  • Leng X, Connell-Crowley L, Goodrich D and Harper JW. . 1997 Curr. Biol. 7: 709–712.

  • Lew DJ, Dulic V and Reed SI. . 1991 Cell 66: 1197–1206.

  • Lovec H, Grzeschiczek A, Kowalski MB and Möröy T. . 1994a EMBO J. 13: 3487–3495.

  • Lovec H, Sewing A, Lucibello FC, Müller R and Möröy, T. . 1994b Oncogene 9: 323–326.

  • Maeda K, Chung Y, Kang S, Ogawa M, Onoda N, Nishiguchi Y, Ikehara T, Nakata B, Okuno M and Sowa M. . 1998 Oncology 55: 145–151.

  • Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF and Sherr CJ. . 1992 Cell 71: 323–334.

  • Motokura T and Arnold A. . 1993 Genes Chromosom Cancer 7: 89–95.

  • Mumberg D, Müller R and Funk M. . 1995 Gene 156: 119–122.

  • Pines J. . 1994 Trends Biochem. Sci. 19: 143–145.

  • Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar SD, Roussel MF and Sherr CJ. . 1993 Genes Dev. 7: 1559–1571.

  • Resnitzky D, Gossen M, Bujard H and Reed SI. . 1994 Mol. Cell. Biol. 14: 1669–1679.

  • Resnitzky D and Reed SI. . 1995 Mol. Cell. Biol. 15: 3463–3469.

  • Rosenberg CL, Kim HG, Shows TB, Kronenberg HM and Arnold A. . 1991a Oncogene 6: 449–453.

  • Rosenberg CL, Motokura T, Kronenberg HM and Arnold A. . 1993 Oncogene 8: 519–521.

  • Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL and Arnold A. . 1991b Proc. Natl. Acad. Sci. USA 88: 9638–9642.

  • Sarcevic B, Lilischkis R and Sutherland RL. . 1997 J. Biol. Chem. 272: 33327–33337.

  • Sewing A, Bürger C, Brüsselbach S, Schalk C, Lucibello FC and Müller R. . 1993 J. Cell Sci. 104: 545–554.

  • Sewing A and Müller R. . 1994 Oncogene 9: 2733–2736.

  • Sikorski RS and Hieter P. . 1989 Genetics 122: 19–27.

  • Tam SW, Theodoras AM, Shay JW, Draetta GF and Pagano M. . 1994 Oncogene 9: 2663–2674.

  • Triezenberg SJ, Kingsbury RC and McKnight SL. . 1988 Genes Dev. 2: 718–729.

  • Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A and Schmidt EV. . 1994 Nature 369: 669–671.

  • Xiong Y, Connolly T, Futcher B and Beach D. . 1991 Cell 65: 691–699.

  • Zwijsen RML, Wientjens E, Klompmaker R, van der Sman J, Bernards R and Michalides RJAM. . 1997 Cell 88: 405–415.

Download references

Acknowledgements

We are grateful to Dr H Lovec for help with REF assays and to Drs T Mäkelä and K Alitalo for pEJ6.6ras, to CJ Sherr for PSK-J3/CDK4 and to F Alt for pKO-Myc. This work was supported by the Dr Mildred Scheel-Stiftung für Krebsforschung.

Author information

Author notes

  1. Jörk Zwicker, Sabine Brüsselbach and Karin U Jooss: The first three authors contributed equally to this paper

Authors and Affiliations

  1. Institut für Molekularbiologie und Tumorforschung (IMT), Philipps-Universität Marburg, Emil-Mannkopff-Strasse 2, Marburg, D-35033, Germany

    Jörk Zwicker, Sabine Brüsselbach, Karin U Jooss, Andreas Sewing, Moira Behn, Frances C Lucibello & Rolf Müller

Authors
  1. Jörk Zwicker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sabine Brüsselbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karin U Jooss
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andreas Sewing
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Moira Behn
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Frances C Lucibello
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rolf Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zwicker, J., Brüsselbach, S., Jooss, K. et al. Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation. Oncogene 18, 19–25 (1999). https://doi.org/10.1038/sj.onc.1202286

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202286

Keywords

This article is cited by

Search

Advanced search

Quick links